LUTS stands for lower urinary tract symptoms, a broad term covering any combination of bladder and urination problems that affect daily life. It’s not a single disease but a group of symptoms that can stem from different causes in men and women. Nearly 70% of adults over 40 experience at least one of these symptoms, and the prevalence climbs with age, reaching roughly 90% in people over 80.
The Three Categories of LUTS
LUTS are grouped into three categories based on when symptoms occur relative to urination: storage, voiding, and post-micturition.
Storage symptoms happen while the bladder is filling. These include needing to urinate frequently during the day, waking up at night to go (nocturia), sudden intense urges that are hard to delay, and leaking urine. This cluster is often called overactive bladder when urgency is the dominant complaint.
Voiding symptoms occur during urination itself. A weak or interrupted stream, difficulty getting the flow started (hesitancy), needing to strain or push, and a stream that stops and starts are all voiding symptoms. These typically point to some form of obstruction or the bladder muscle not contracting effectively.
Post-micturition symptoms show up right after you finish. The two main ones are a persistent feeling that your bladder didn’t fully empty and dribbling after you’ve left the toilet. These symptoms have received less clinical attention than the other two categories, but they can be just as disruptive.
Most people with LUTS experience symptoms from more than one category at the same time.
What Causes LUTS in Men
In men, prostate enlargement (benign prostatic hyperplasia, or BPH) is the most common driver. The prostate surrounds the urethra just below the bladder, so as it grows, it can squeeze the urethra and increase resistance to urine flow. The prostate’s outer capsule transmits the pressure of this growth inward, further narrowing the channel. When the obstruction becomes significant enough, both the flow of urine and the bladder itself are affected.
Over time, the bladder adapts to working harder against this obstruction. The muscle wall thickens and can become overactive, triggering urgency and frequency even when the bladder isn’t full. In some cases, the opposite happens: the bladder muscle weakens and can no longer empty completely, leading to that sensation of incomplete emptying and a need to go again shortly after finishing.
Not all male LUTS come from the prostate, though. Bladder dysfunction, urethral narrowing, neurological conditions, and infections can all produce similar symptoms. Importantly, the symptoms alone can’t reliably distinguish prostate-related obstruction from other causes, which is why testing matters.
What Causes LUTS in Women
Women experience LUTS at slightly higher rates than men overall (about 73% vs. 66% in adults over 40), but the causes are different. Overactive bladder is more common in women, with nearly 40% of women over 40 reporting symptoms compared to about 27% of men.
Pelvic organ prolapse is a significant contributor. When the bladder, uterus, or rectum shifts downward due to weakened pelvic floor support, the displaced tissue can kink or compress the urethra, creating the same type of obstruction that prostate enlargement causes in men. This obstruction irritates the bladder and triggers urgency, frequency, and incontinence. Correcting the prolapse often resolves these bladder symptoms, though it can sometimes unmask stress incontinence that the prolapse was inadvertently preventing.
Stress urinary incontinence, where urine leaks during coughing, sneezing, or physical activity, is another common form of LUTS in women. Mixed incontinence, a combination of stress and urgency types, is also frequent.
How LUTS Severity Is Measured
Doctors typically start with a standardized questionnaire called the International Prostate Symptom Score (IPSS), which despite its name is used for women too. It asks seven questions about specific symptoms over the past month, each scored 0 to 5. The total, out of 35, places you in one of three categories:
- Mild: 0 to 7 points
- Moderate: 8 to 19 points
- Severe: 20 to 35 points
If symptoms suggest obstruction, a uroflowmetry test can measure how fast urine flows. You simply urinate into a special toilet, and the device records your peak flow rate, average rate, and total volume. A peak flow rate below 15 milliliters per second suggests a blockage. After you finish, an ultrasound can check how much urine remains in the bladder (post-void residual volume). Both tests are painless and noninvasive.
Lifestyle Changes That Help
For mild to moderate symptoms, adjustments to daily habits can make a meaningful difference. The core strategy for nocturia is shifting your fluid intake earlier in the day and cutting back on liquids after dinner. Reducing or eliminating caffeine helps with both urgency and frequency.
Diet plays a broader role than many people realize. Higher intake of red meat, fat, and refined starches has been linked to worse LUTS, while diets rich in vegetables, fruits, and adequate vitamin D are associated with lower risk. Obesity is an independent risk factor, and higher total calorie intake correlates with more severe symptoms. Maintaining a healthy weight may not eliminate LUTS, but it can reduce the burden noticeably.
Micronutrients also appear to matter. Higher blood levels of vitamin E, selenium, and lycopene (the pigment in tomatoes) have been associated with reduced LUTS risk in population studies.
Medications for LUTS
When lifestyle changes aren’t enough, several classes of medication target different parts of the problem. The choice depends on whether your symptoms are primarily storage, voiding, or both.
For voiding symptoms related to obstruction, alpha-blockers work by relaxing the smooth muscle around the bladder neck and prostate, reducing resistance to urine flow. These are typically the first medication tried for men with bothersome LUTS. A second class, 5-alpha reductase inhibitors, works differently: they block the conversion of testosterone into its more potent form, which gradually shrinks the prostate over months. These are used when the prostate is significantly enlarged.
For storage symptoms like urgency and frequency, anticholinergics relax the bladder muscle to reduce involuntary contractions. A newer alternative, beta-3 agonists, increases bladder capacity by relaxing the bladder wall through a different pathway. Both approaches aim to let the bladder hold more urine comfortably.
Some patients benefit from combinations, particularly an alpha-blocker paired with another class. The European Association of Urology’s 2024 guidelines added new recommendations for combining alpha-blockers with PDE-5 inhibitors (the same class used for erectile dysfunction), reflecting growing evidence that this combination addresses both urinary and sexual symptoms.
Surgical and Minimally Invasive Options
Surgery becomes relevant when medications fail or cause intolerable side effects. Transurethral resection of the prostate (TURP) has been the standard surgical treatment for decades. It involves removing obstructive prostate tissue through the urethra, but it carries risks of bleeding, sexual dysfunction, and anesthesia complications, particularly in older patients.
Two newer, minimally invasive procedures offer alternatives. Rezum delivers steam (water vapor) through the urethra to destroy excess prostate tissue, which the body then reabsorbs over weeks. Urolift takes a mechanical approach, placing small implants that pin back the obstructing lobes of the prostate to open the urinary channel. Both procedures can often be done with lighter sedation and shorter recovery times than TURP.
Short-term complication rates for both are low, with most issues classified as mild. The longer-term picture differs, however. Over five years, Urolift had a cumulative complication rate of 33.6% compared to 15.4% for Rezum, largely driven by a much higher rate of surgical reintervention: nearly 23% of Urolift patients needed a second procedure within five years, versus about 4% for Rezum.